Indoco Remedies gets US FDA nod to manufacture uric acid drug

| Updated on January 18, 2018 Published on July 29, 2016

Indoco Remedies has secured US Food & Drug Administration approval to manufacture and sell the generic of Zyloprim tablets, the company said in an exchange filing on Friday. Indoco Remedies will sell the generic allopurinol tablets in 100 mg and 300 mg strengths. Allopurinol is primarily used in the treatment of excess uric acid in blood. Shares of Indoco Remedies were down 4.8 per cent at ₹307.20 on the NSE.

Published on July 29, 2016
This article is closed for comments.
Please Email the Editor